NCT06797492 (REVISA) is a NA clinical trial of Shoulder Physical Examination in Shoulder Musculoskeletal Disorders, sponsored by Fondazione Policlinico Universitario Campus Bio-Medico.

Who is sponsoring NCT06797492?

NCT06797492 is sponsored by Fondazione Policlinico Universitario Campus Bio-Medico.

What condition does NCT06797492 study?

NCT06797492 studies Shoulder Musculoskeletal Disorders.

Is NCT06797492 still recruiting?

NCT06797492 is currently recruiting now. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT06797492: REVISA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality for Shoulder Rehabilitation: New Approaches and Applications in Orthopedics

Recruiting now NA Last updated 2 March 2026

What this trial tests

NA trial testing Shoulder Physical Examination in Shoulder Musculoskeletal Disorders in 50 participants. Currently enrolling.

Timeline

1 September 2025

Primary endpoint
1 June 2026

1 December 2027

Quick facts

Lead sponsor	Fondazione Policlinico Universitario Campus Bio-Medico
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	50
Start date	1 September 2025
Primary completion	1 June 2026
Estimated completion	1 December 2027
Sites	2 locations across Italy

Drugs / interventions tested

Shoulder Physical Examination
Shoulder Rehabilitation in a Virtual Environment
Usability assessment and presence and co-presence evaluation

Conditions studied

Shoulder Musculoskeletal Disorders — all drugs for Shoulder Musculoskeletal Disorders →

Sponsor

Fondazione Policlinico Universitario Campus Bio-Medico

Who can join

Adults 18 to 75, any sex, with Shoulder Musculoskeletal Disorders. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Change in Usability Level of the VR System Using the System Usability Scale (SUS)
Time frame: Across four rehabilitation phases: T1 (0-4/6 weeks), T2 (6-12 weeks), T3 (12-20 weeks), and T4 (beyond 20 weeks)
The usability of the VR system during the execution of several rehabilitation exercises will be assessed using the System Usability Scale (SUS). The SUS is a widely used questionnaire that measures the overall usability of a system, based on a 10-item scale that assesses the ease of use, satisfaction, and functionality of the system from the user's perspective. Scores range from 0 to 100, with hig

Sponsor's own description

Goal: The clinical investigation involves the evaluation of the usability level of the VR system, sense of presence, and co-presence during the execution of various rehabilitation exercises through specific questionnaires. Participant Population: The study will enroll 50 patients with shoulder musculoskeletal disorders will be enrolled Main Questions: * How does the integration of Virtual Reality (VR) in rehabilitation programs impact the usability of the system for patients with shoulder musculoskeletal disorders? * To what extent does the sense of presence experienced by patients using VR systems influence their motivation and adherence to rehabilitation exercises? * How do patients with shoulder musculoskeletal disorders perceive the co-presence in VR rehabilitation scenarios, and how does it affect their overall treatment experience? Participant Tasks: * Shoulder Physical Examination * Instructions to the patient on exercises to be performed using Oculus and selection of customizable settings on the VR app * Execution of the protocol developed for shoulder rehabilitation in a virtual environment * Evaluation of the usability of the VR system, sense of presence, and co-presence through different validated scales

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fondazione Policlinico Universitario Campus Bio-Medico trials

Trials by the same sponsor.

NCT06873685 — Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life · NA · recruiting
NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
NCT07029126 — Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symp · recruiting
NCT06539000 — Preoperative Risk Score for Postoperative Right Ventricular Dysfunction in Adult Cardiac Surgery · completed
NCT06974474 — Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06797492 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Campus Bio-Medico
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06797492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing